Piclozotan

DB12361InvestigationalSmall molecule

Piclozotan has been investigated for the treatment of Parkinson's Disease.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 1A
Curator reviewed
Formula / weight: C₂₃H₂₄ClN₃O₂ · 409.91 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyURMTUEWUIGOJBW-UHFFFAOYSA-NSMILESClC1=COC2=CC=CC=C2C(=O)N1CCCCN1CCC(=CC1)C1=CC=CC=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,068Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Piclozotan, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.